MENU
+Compare
NPCE
Stock ticker: NASDAQ
AS OF
Dec 18, 01:12 PM (EDT)
Price
$11.00
Change
-$0.52 (-4.51%)
Capitalization
385.2M

NPCE Neuropace Forecast, Technical & Fundamental Analysis

NPCE
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
A.I.Advisor
a Summary for NPCE with price predictions
Dec 17, 2024

Aroon Indicator for NPCE shows an upward move is likely

NPCE's Aroon Indicator triggered a bullish signal on December 12, 2024. Tickeron's A.I.dvisor detected that the AroonUp green line is above 70 while the AroonDown red line is below 30. When the up indicator moves above 70 and the down indicator remains below 30, it is a sign that the stock could be setting up for a bullish move. Traders may want to buy the stock or look to buy calls options. A.I.dvisor looked at 126 similar instances where the Aroon Indicator showed a similar pattern. In of the 126 cases, the stock moved higher in the days that followed. This puts the odds of a move higher at .

Price Prediction Chart

Technical Analysis (Indicators)

Bullish Trend Analysis

Following a 3-day Advance, the price is estimated to grow further. Considering data from situations where NPCE advanced for three days, in of 193 cases, the price rose further within the following month. The odds of a continued upward trend are .

Bearish Trend Analysis

The 10-day RSI Indicator for NPCE moved out of overbought territory on December 04, 2024. This could be a bearish sign for the stock. Traders may want to consider selling the stock or buying put options. Tickeron's A.I.dvisor looked at 17 similar instances where the indicator moved out of overbought territory. In of the 17 cases, the stock moved lower in the following days. This puts the odds of a move lower at .

The Stochastic Oscillator may be shifting from an upward trend to a downward trend. In of 36 cases where NPCE's Stochastic Oscillator exited the overbought zone, the price fell further within the following month. The odds of a continued downward trend are .

The Momentum Indicator moved below the 0 level on December 17, 2024. You may want to consider selling the stock, shorting the stock, or exploring put options on NPCE as a result. In of 79 cases where the Momentum Indicator fell below 0, the stock fell further within the subsequent month. The odds of a continued downward trend are .

The Moving Average Convergence Divergence Histogram (MACD) for NPCE turned negative on December 11, 2024. This could be a sign that the stock is set to turn lower in the coming weeks. Traders may want to sell the stock or buy put options. Tickeron's A.I.dvisor looked at 33 similar instances when the indicator turned negative. In of the 33 cases the stock turned lower in the days that followed. This puts the odds of success at .

Following a 3-day decline, the stock is projected to fall further. Considering past instances where NPCE declined for three days, the price rose further in of 62 cases within the following month. The odds of a continued downward trend are .

NPCE broke above its upper Bollinger Band on December 03, 2024. This could be a sign that the stock is set to drop as the stock moves back below the upper band and toward the middle band. You may want to consider selling the stock or exploring put options.

Fundamental Analysis (Ratings)

The Tickeron Price Growth Rating for this company is (best 1 - 100 worst), indicating steady price growth. NPCE’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron Valuation Rating of (best 1 - 100 worst) indicates that the company is fair valued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (18.657) is normal, around the industry mean (23.300). P/E Ratio (0.000) is within average values for comparable stocks, (83.485). Projected Growth (PEG Ratio) (0.000) is also within normal values, averaging (5.667). Dividend Yield (0.000) settles around the average of (0.018) among similar stocks. P/S Ratio (5.371) is also within normal values, averaging (43.338).

The Tickeron SMR rating for this company is (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

The Tickeron PE Growth Rating for this company is (best 1 - 100 worst), pointing to worse than average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

The Tickeron Profit vs. Risk Rating rating for this company is (best 1 - 100 worst), indicating that the returns do not compensate for the risks. NPCE’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 88, placing this stock worse than average.

View a ticker or compare two or three
NPCE
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Ad is loading...
A.I. Advisor
published Earnings

NPCE is expected to report earnings to rise 30.05% to -24 cents per share on March 05

Neuropace NPCE Stock Earnings Reports
Q4'24
Est.
$-0.25
Q3'24
Beat
by $0.08
Q2'24
Beat
by $0.04
Q1'24
Est.
$-0.32
Q4'23
Beat
by $0.09
The last earnings report on November 12 showed earnings per share of -18 cents, beating the estimate of -27 cents. With 5.13K shares outstanding, the current market capitalization sits at 385.20M.
A.I. Advisor
published General Information

General Information

Industry MedicalSpecialties

Profile
Fundamentals
Details
Industry
N/A
Address
455 N. Bernardo Avenue
Phone
+1 650 237-2700
Employees
167
Web
https://www.neuropace.com
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
SLRYX55.03N/A
N/A
SEI Large Cap Growth Y (SIMT)
AZEMX11.25N/A
N/A
Alger Emerging Markets Z
SCVEX18.93-0.07
-0.37%
Hartford Schroders International Stk A
TGVFX52.24-0.25
-0.48%
Touchstone Growth Opportunities A
DGIFX25.51-0.17
-0.66%
Disciplined Growth Investors

NPCE and Stocks

Correlation & Price change

A.I.dvisor indicates that over the last year, NPCE has been loosely correlated with FNA. These tickers have moved in lockstep 36% of the time. This A.I.-generated data suggests there is some statistical probability that if NPCE jumps, then FNA could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To NPCE
1D Price
Change %
NPCE100%
+0.44%
FNA - NPCE
36%
Loosely correlated
-3.54%
STVN - NPCE
33%
Loosely correlated
+1.46%
SHC - NPCE
31%
Poorly correlated
+0.69%
IRIX - NPCE
28%
Poorly correlated
-1.47%
IRMD - NPCE
27%
Poorly correlated
-0.34%
More